Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT03386851
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with schizophrenia or bipolar 1 disorder
* Patients who are prescribed Abilify Maintena® Injections treatment as per investigator's medical judgment
* Patients giving written authorization to use their personal and health data and starting Abilify Maintena® Injections treatment after agreement is in place and investigators provide the explanation about objective and feature of the surveillance
Exclusion Criteria:
* Patients with known hypersensitivity to Aripiprazole or any excipients of Abilify Maintena® Injections
* Elderly patients with dementia related psychosis
* Patients who have been treated with Abilify Maintena® Injections
* Patients with score 0(Not assessed) or 1(Normal, not at all ill) in the Clinical Global Impression-Severity(CGI-S)
* Patients participating in other clinical trial
* All patients who in medical judgment of the investigator would not be appropriate for inclusion criteria in the surveillance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03386851
Study Brief:
Protocol Section:
NCT03386851